Score Overview
See the full market ranking โ
Bioventus Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 430M to $ 568M and net income grew from $ 19M to $ 22M. Revenue increased in 80% of the years measured; net income in 80%.
Bioventus Inc currently holds a 5-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 13.91 | โ |
1 Year2025-08-12 | $ 7.31 | 90.36% |
5 Years2021-08-12 | $ 15.16 | -8.21% |
All Time2021-02-11 | $ 19.21 | -27.56% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-02-11 |
|---|---|---|---|---|
| Price | $ 13.91 | $ 7.31 | $ 15.16 | $ 19.21 |
| Return | โ | 90.36% | -8.21% | -27.56% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 581M | $ 54M | $ 29M |
| 2025 | $ 568M | $ 22M | $ 51M |
| 2024 | $ 573M | -$ 33M | $ 41M |
| 2023 | $ 512M | -$ 156M | $ 36M |
| 2022 | $ 512M | -$ 158M | $ 30M |
| IPO2021 | $ 430M | $ 19M | $ 43M |
Explore beyond BVS
You're looking at Bioventus Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.